Open access
Open access
Powered by Google Translator Translator

Endocrinology (all articles)

Review | Cardiovascular outcomes in type 1 and type 2 diabetes

23 Jan, 2023 | 13:18h | UTC

Cardiovascular outcomes in type 1 and type 2 diabetes – Diabetologia

 

Commentary on Twitter

Article under a http://creativecommons.org/licenses/by/4.0/. License

 


M-A of Observational Studies | Physical activity and risk of major diabetes-related complications in individuals with diabetes

23 Jan, 2023 | 13:17h | UTC

Physical Activity and Risk of Major Diabetes-Related Complications in Individuals With Diabetes: A Systematic Review and Meta-Analysis of Observational Studies – Diabetes Care

 

Commentary on Twitter

 


Health and economic outcomes associated with musculoskeletal disorders attributable to high BMI in 192 countries

23 Jan, 2023 | 13:16h | UTC

Health and Economic Outcomes Associated With Musculoskeletal Disorders Attributable to High Body Mass Index in 192 Countries and Territories in 2019 – JAMA Network Open

 


Consensus Statement | Proposed algorithm for pharmacotherapy in people with type 2 diabetes

20 Jan, 2023 | 14:41h | UTC

A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes – Journal of Diabetes Investigation

Related: Guideline | ADA 2023 Standards of Medical Care in Diabetes.

 


Consensus Recommendations | Sick day medication guidance for people with diabetes, kidney, or cardiovascular disease

19 Jan, 2023 | 14:31h | UTC

Consensus Recommendations for Sick Day Medication Guidance for People With Diabetes, Kidney, or Cardiovascular Disease: A Modified Delphi Process – American Journal of Kidney Diseases

 

Commentary on Twitter

 


Metomidate PET-CT vs. adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial

19 Jan, 2023 | 14:19h | UTC

[11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial – Nature Medicine

News Release: Ten-minute scan enables detection and cure of the commonest cause of high blood pressure – Queen Mary University of London

 


2022 Consensus Guidelines on the management of diabetes in children

19 Jan, 2023 | 14:16h | UTC

Editorial: ISPAD Clinical Practice Consensus Guidelines 2022

ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes

ISPAD Clinical Practice Consensus Guidelines 2022: Assessment and management of hypoglycemia in children and adolescents with diabetes

ISPAD Clinical Practice Consensus Guidelines 2022: Exercise in children and adolescents with diabetes

ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring

ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis-related diabetes in children and adolescents

ISPAD Clinical Practice Consensus Guidelines 2022: Ramadan and other religious fasting by young people with diabetes

ISPAD Clinical Practice Consensus Guidelines 2022: Managing diabetes in preschoolers

ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents

 


Cross sectional-study | Higher beverage fructose intake linked to adverse profiles on multiple cardiometabolic biomarkers

17 Jan, 2023 | 13:17h | UTC

Fructose consumption from different food sources and cardiometabolic biomarkers: cross-sectional associations in US men and women – The American Journal of Clinical Nutrition

Commentary: Beverage fructose intake may lead to an abnormal cardiometabolic profile – News Medical

 


Podcast | Adrenal incidentalomas

17 Jan, 2023 | 13:16h | UTC

#377 Adrenal Incidentalomas with Dr. William Young – The Curbsiders

 


Synopsis | Endocrine Society hypercalcemia of malignancy guidelines

15 Jan, 2023 | 22:13h | UTC

Endocrine Society Hypercalcemia of Malignancy Guidelines – JAMA Oncology (free for a limited period)

Original article: Guideline | Treatment of hypercalcemia of malignancy in adults

 


Crossover RCT | Preliminary study showed closed-loop insulin delivery might improve glycemic control in some adults with Type 2 DM

15 Jan, 2023 | 19:56h | UTC

Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial – Nature Medicine

News Release: Artificial pancreas successfully trialed for use by type 2 diabetes patients – University of Cambridge

Commentary: Artificial Pancreas Device May Help Folks With Type 2 Diabetes – HealthDay

 


Report | Obstacles and opportunities in managing coexisting obesity and CKD

13 Jan, 2023 | 13:30h | UTC

Obstacles and Opportunities in Managing Coexisting Obesity and CKD: Report of a Scientific Workshop Cosponsored by the National Kidney Foundation and The Obesity Society – American Journal of Kidney Diseases

 


M-A | Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy effects on obesity comorbidities

12 Jan, 2023 | 13:00h | UTC

Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy effects on obesity comorbidities: A systematic review and meta-analysis – Frontiers in Surgery

 


M-A | Blood endotoxin levels as biomarker of non-alcoholic fatty liver disease

12 Jan, 2023 | 12:57h | UTC

Blood endotoxin levels as biomarker of non-alcoholic fatty liver disease: a systematic review and meta-analysis – Clinical Gastroenterology and Hepatology

 


M-A | The prevalence of obesity among children with type 2 DM

12 Jan, 2023 | 12:53h | UTC

The Prevalence of Obesity Among Children With Type 2 Diabetes: A Systematic Review and Meta-analysis – JAMA Network Open

Commentary: Not All Pediatric Cases of Type 2 Diabetes Have Obesity – HealthDay

 

Commentary on Twitter

 


NICE Guideline | Thyroid cancer: assessment and management

11 Jan, 2023 | 14:34h | UTC

Thyroid cancer: assessment and management – National Institute for Health and Care Excellence

 


Guideline Synopsis | Diabetes management in chronic kidney disease

10 Jan, 2023 | 14:52h | UTC

Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update – Annals of Internal Medicine

News Release: Group summarizes new guidelines for treating patients with diabetes and chronic kidney disease – American College of Physicians

Commentary: Layered Approach Recommended for Patients With Diabetes, CKD – HealthDay

Original Guideline: KDIGO 2022 Clinical practice guideline for diabetes management in chronic kidney disease.

 


AAP Guideline | Evaluation and treatment of children and adolescents with obesity

10 Jan, 2023 | 14:54h | UTC

Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity – Pediatrics

Executive Summary: Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity – Pediatrics

News Release: American Academy of Pediatrics Issues Its First Comprehensive Guideline on Evaluating, Treating Children and Adolescents With Obesity – American Academy of Pediatrics

Commentaries:

Childhood obesity requires early, aggressive treatment, new guidelines say – NPR

New guidance: Use drugs, surgery early for obesity in kids – Associated Press

 


Diagnostic accuracy study | Home waking salivary cortisone to screen for adrenal insufficiency

10 Jan, 2023 | 14:47h | UTC

Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency – NEJM Evidence

Commentary: At-home saliva test to diagnose adrenal insufficiency makes a difference to patients’ health – News Medical

 

Commentary on Twitter

 


Restoring mortality data in the FOURIER trial of evolocumab in patients with CVD: a reanalysis based on regulatory data

10 Jan, 2023 | 14:49h | UTC

Restoring mortality data in the FOURIER cardiovascular outcomes trial of evolocumab in patients with cardiovascular disease: a reanalysis based on regulatory data – BMJ Open

Commentaries: 

Yet Another Story on Re-Analyzing a Major Trial – Sensible Medicine

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees – TCTMD

Experts Issue Caution for Evolocumab Following New Review of FOURIER Data; Amgen Disputes the Claims – AJMC

 


Podcast | Endocrine emergencies

10 Jan, 2023 | 14:32h | UTC

#372 Endocrine Emergencies featuring Dr. Sara Markley Webster – The Curbsiders

 


ACP Guideline | Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults

9 Jan, 2023 | 14:59h | UTC

Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians – Annals of Internal Medicine

See also: Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians – Annals of Internal Medicine

News Release: American College of Physicians recommends bisphosphonates for initial treatment for osteoporosis in males and postmenopausal females diagnosed with primary osteoporosis

Summary for Patients: Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults

 


Guideline | Treatment of hypercalcemia of malignancy in adults

9 Jan, 2023 | 14:46h | UTC

Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline – The Journal of Clinical Endocrinology & Metabolism

See also: A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline on the Treatment of Hypercalcemia of Malignancy in Adults – The Journal of Clinical Endocrinology & Metabolism

News Release: Experts provide first framework for treating hypercalcemia of malignancy in adults – News Medical

 


The year in cardiovascular medicine 2022: the top 10 papers in dyslipidemias

9 Jan, 2023 | 14:26h | UTC

The year in cardiovascular medicine 2022: the top 10 papers in dyslipidaemias – European Heart Journal

 

Commentary on Twitter

 


WHO manual on sugar-sweetened beverage taxation policies to promote healthy diets.

16 Dec, 2022 | 13:52h | UTC

WHO manual on sugar-sweetened beverage taxation policies to promote healthy diets – World Health Organization

News Release: WHO calls on countries to tax sugar-sweetened beverages to save lives – World Health Organization

Related:

M-A: Outcomes following taxation of sugar-sweetened beverages.

Public Policies to Reduce Sugary Drink Consumption in Children and Adolescents – Pediatrics

Cutting back on sugar-sweetened beverages: What works? – Cochrane Library

Association of a Beverage Tax on Sugar-Sweetened and Artificially Sweetened Beverages With Changes in Beverage Prices and Sales at Chain Retailers in a Large Urban Setting – JAMA

Impact of sugar‐sweetened beverage taxes on purchases and dietary intake: Systematic review and meta‐analysis – Obesity Reviews

Association between tax on sugar sweetened beverages and soft drink consumption in adults in Mexico: open cohort longitudinal analysis of Health Workers Cohort Study – The BMJ

Potential impact on prevalence of obesity in the UK of a 20% price increase in high sugar snacks: modelling study – The BMJ

Changes in food purchases after the Chilean policies on food labelling, marketing, and sales in schools: a before and after study – The Lancet Planetary Health

Association of a Sweetened Beverage Tax With Soda Consumption in High School Students – JAMA Pediatrics

Sugar-sweetened beverage taxes: Lessons to date and the future of taxation – PLOS Medicine

Banning the promotion of soft drinks could be more effective than a sugar tax – The Conversation

Sugar tax: why health experts want it but politicians and industry are resisting – The Guardian

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.